![Dana Aftab](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 30 M $ al 31/05/2026
Dana T.
Aftab is currently the CSO, EVP-Discovery, Research & Development at Exelixis, Inc., a position held since 2025.
Education includes a doctorate from Yale University and an undergraduate degree from the University of California, Santa Barbara.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EXELIXIS, INC. 0,24 % | 26/05/2026 | 600.576 ( 0,24 % ) | 30 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EXELIXIS, INC. | Director Técnico/Científico/I+D | 15/12/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Santa Barbara
 University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
